GE HealthCare Technologies (NASDAQ:GEHC) Raised to “Hold” at BMO Capital Markets

Posted by Francis Steltz on Jul 10th, 2026

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) was upgraded by research analysts at BMO Capital Markets to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

Several other equities analysts have also recently issued reports on the company. Weiss Ratings cut GE HealthCare Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, May 15th. BNP Paribas Exane reduced their target price on GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Mizuho decreased their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. JPMorgan Chase & Co. lowered their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Finally, UBS Group raised GE HealthCare Technologies from a “sell” rating to a “neutral” rating and dropped their price objective for the company from $75.00 to $69.00 in a research report on Thursday, May 21st. Ten investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.71.

Get Our Latest Stock Analysis on GEHC

GE HealthCare Technologies Stock Up 0.0%

Shares of GE HealthCare Technologies stock opened at $64.70 on Wednesday. The company has a 50-day simple moving average of $63.33 and a two-hundred day simple moving average of $72.71. The stock has a market capitalization of $29.43 billion, a PE ratio of 15.48, a price-to-earnings-growth ratio of 1.76 and a beta of 0.72. GE HealthCare Technologies has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts anticipate that GE HealthCare Technologies will post 4.89 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO James Saccaro purchased 3,310 shares of the stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the acquisition, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Peter J. Arduini purchased 4,169 shares of the stock in a transaction dated Thursday, April 30th. The shares were purchased at an average cost of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 21,847 shares of company stock worth $1,361,355 in the last 90 days. Insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Hedge funds have recently bought and sold shares of the company. Laurel Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the fourth quarter valued at about $26,000. Optima Capital LLC purchased a new position in GE HealthCare Technologies in the fourth quarter worth about $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $27,000. Montag A & Associates Inc. grew its stake in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 331.6% during the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 262 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.